The emerging role of noncoding RNAs in the PI3K/AKT/mTOR signalling pathway in breast cancer
- 30 January 2024
- journal article
- review article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 255, 155180
Abstract
No abstract availableKeywords
Funding Information
- University of Bisha
- Prince Sattam bin Abdulaziz University (PSAU/2023/R/1445)
This publication has 123 references indexed in Scilit:
- Estrogenic endocrine disruptors: Molecular mechanisms of actionEnvironment International, 2015
- MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor geneBreast Cancer Research, 2015
- 3,6-Dihydroxyflavone Suppresses Breast Carcinogenesis by Epigenetically Regulating miR-34a and miR-21Cancer Prevention Research, 2015
- An evaluation and replication of miRNAs with disease stage and colorectal cancer‐specific mortalityInternational Journal of Cancer, 2014
- The Exposure of Breast Cancer Cells to Fulvestrant and Tamoxifen Modulates Cell Migration DifferentlyBioMed Research International, 2013
- A Multiprotein Binding Interface in an Intrinsically Disordered Region of the Tumor Suppressor Protein Interferon Regulatory Factor-1Journal of Biological Chemistry, 2011
- Small-Molecule Protein Kinase Inhibitors and Their Effects on the Immune System: Implications for Cancer TreatmentImmunotherapy, 2011
- Estradiol, tamoxifen and ICI 182,780 alter α3 and β1 integrin expression and laminin-1 adhesion in oral squamous cell carcinoma cell culturesOral Oncology, 2008
- Thrombin activates a Y box–binding protein (DNA-binding protein B) in endothelial cellsJournal of Clinical Investigation, 2000
- BREAST CARCINOMA IN SITUAnz Journal of Surgery, 1992